Serum vitamin D level and prehypertension among subjects free of hypertension

Kidney and Blood Pressure Research

Volumn 35, Issue 2, 2012, Pages 106-113

  Sabanayagam, Charumathi ^a   Shankar, Anoop ^a   Somasundaram, Shanmugasundaram ^b  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KS Hospital   (India)

Author keywords

Blood pressure; Prehypertension; Vitamin D

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; VITAMIN D;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; ETHNIC DIFFERENCE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREHYPERTENSION; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; VITAMIN BLOOD LEVEL;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; NUTRITION SURVEYS; PREHYPERTENSION; PREVALENCE; RISK FACTORS; SMOKING; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84858053010     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000330716     Document Type: Article

References (40)

1. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF: Vitamin D Deficiency: An important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008;52:1949-1956.
2. Baz-Hecht M, Goldfine AB: The impact of vitamin D deficiency on diabetes and cardiovascular risk. Curr Opin Endocrinol Diabetes Obes 2010;17:113-119.
3. Wang TJ, Pencina MJ, Booth SL, et al: Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503-511.
4. Forman JP, Curhan GC, Taylor EN: Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 2008;52:828-832.
5. Forman JP, Giovannucci E, Holmes MD, et al: Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007;49:1063-1069. (Pubitemid 351664326)
6. Judd SE, Nanes MS, Ziegler TR, Wilson PW, Tangpricha V: Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the Third National Health and Nutrition Examination Survey. Am J Clin Nutr 2008;87:136-141.
7. Schmitz KJ, Skinner HG, Bautista LE, et al: Association of 25-hydroxyvitamin D with blood pressure in predominantly 25-hydroxyvitamin D deficient Hispanic and African Americans. Am J Hypertens 2009;22:867-870.
8. Scragg R, Sowers M, Bell C: Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 2007;20:713-719. (Pubitemid 46936167)
9. Zhao G, Ford ES, Li C, Kris-Etherton PM, Etherton TD, Balluz LS: Independent associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with blood pressure among US adults. J Hypertens 2010;28:1821-1828.
10. Gupta AK, Brashear MM, Johnson WD: Prediabetes and prehypertension in healthy adults are associated with low vitamin D levels. Diabetes Care 2011;34:658-660.
11. Chonchol M, Scragg R: 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int 2007;71:134-139. (Pubitemid 46094686)
12. Barri YM: Hypertension and kidney disease: a deadly connection. Curr Cardiol Rep 2006;8:411-417.
13. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM: C-Reactive protein and the risk of developing hypertension. JAMA 2003;290:2945-2951. (Pubitemid 37505526)
14. Nagpal S, Na S, Rathnachalam R: Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005;26:662-687. (Pubitemid 41127276)
15. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ: Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 2008;57:2619-2625.
16. Jorde R, Figenschau Y, Emaus N, Hutchinson M, Grimnes G: Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension. Hypertension 2010;55:792-798.
17. Chobanian AV, Bakris GL, Black HR, et al: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-2572. (Pubitemid 37430158)
18. Liszka HA, Mainous AG, III, King DE, Everett CJ, Egan BM: Prehypertension and cardiovascular morbidity. Ann Fam Med 2005;3:294-299. (Pubitemid 41176304)
19. Vasan RS, Larson MG, Leip EP, et al: Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001;345:1291-1297.
20. Gupta AK, McGlone M, Greenway FL, Johnson WD: Prehypertension in disease-free adults: a marker for an adverse cardiometabolic risk profile. Hypertens Res 2010;33:905-910.
21. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D: Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001;358:1682-1686. (Pubitemid 33124327)
22. National Center for Health Statistics: The Third National Health and Nutrition Examination Survey: reference manuals and reports [article online]. Available at: www.cdc.gov/nchs/data/nhanes/nh3rrm.htm [accessed April 29, 2010] 1996.
23. National Center for Health Statistics: Analytic and reporting guidelines: NHANES III [article online]. Available at: www.cdc.gov/ nchs/data/nhanes/ nhanes3/nh3gui.pdf [accessed April 29, 2010] 1996.
24. Perloff D, Grim C, Flack J, et al: Human blood pressure determination by sphygmomanometry. Circulation 1993;88:2460-2470.
25. National Center for Health Statistics: Laboratory procedures used for NHANES III. Available at: www.cdc.gov/nchs/data/nhanes/nhanes3/cdrom/nchs/ manuals/labman.pdf [accessed April 29, 2010] 1996.
26. Expert Committee on the Diagnosis of Diabetes Mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26(suppl 1):S5-S20.
27. Haddad JG Jr, Hahn TJ: Natural and synthetic sources of circulating 25-hydroxyvitamin D in man. Nature 1973;244:515-517.
28. Hintzpeter B, Mensink GB, Thierfelder W, Muller MJ, Scheidt-Nave C: Vitamin D status and health correlates among German adults. Eur J Clin Nutr 2008;62:1079-1089.
29. Hypponen E, Boucher BJ, Berry DJ, Power C: 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 2008;57:298-305.
30. Lee DM, Rutter MK, O'Neill TW, et al: Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men. Eur J Endocrinol 2009;161:947-954.
31. Jorde R, Figenschau Y, Emaus N, Hutchinson M, Grimnes G: Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension. Hypertension 2010;55:792-798.
32. Margolis KL, Ray RM, Van Horn L, et al: Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial. Hypertension 2008;52:847-855.
33. Jorde R, Sneve M, Torjesen P, Figenschau Y: No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med 2010;267:462-472.
34. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP: 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002;110:229-238. (Pubitemid 34787360)
35. Simpson RU, Hershey SH, Nibbelink KA: Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol 2007;103:521-524. (Pubitemid 46420533)
36. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and metaanalysis. J Clin Endocrinol Metab 2007;92:2017-2029. (Pubitemid 46997093)
37. Talmor Y, Golan E, Benchetrit S, et al: Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells. Am J Physiol Renal Physiol 2008;294:F1059-F1064.
38. Talmor Y, Bernheim J, Klein O, Green J, Rashid G: Calcitriol blunts pro-atherosclerotic parameters through NFkappaB and p38 in vitro. Eur J Clin Invest 2008;38:548-554. (Pubitemid 352019134)
39. Freundlich M, Quiroz Y, Zhang Z, et al: Suppression of renin-angiotensin gene expression in the kidney by paricalcitol. Kidney Int 2008;74:1394-1402.
40. Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM: Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab 2007;92:3517-3522. (Pubitemid 47435329)